Ovid Therapeutics Inc (OVID) Stock Price, Quote & News

Company Profile

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 661 7661

Fax: 646 661 4027

Website: www.ovidrx.com

Address:

441 Ninth Avenue, 14th Floor, New York, United States

Jakezilla727 Jul. 31 at 1:20 PM

$OVID Therapeutics participating in BTIG biotech conference—OV329 Phase 1 readout comes Q3 2025, OV350 trials starting next year. Novel CNS pipeline. Dip opportunities near $0.50—could bounce back in momentum. It's already starting up in pre-market 👍

0 · Reply

Jtlo Jul. 30 at 11:01 PM

$OVID looking for next leg up and hopefully that comes with updates on the phase 1 - Looking for 2-3

0 · Reply

Jakezilla727 Jul. 30 at 2:26 PM

$OVID let's go🔥 I think it has potential to rise to 55 get in on the dip, it's just the star to the day.

0 · Reply

Trade_Weaver Jul. 29 at 11:46 PM

$OVID lets send this to the mood

0 · Reply

Jtlo Jul. 29 at 11:42 AM

$INTS reminds me when I got into $VOR when it was .22 cents $OVID next leg up? Looking to be over a dollar soon 🤞

0 · Reply

lucabrix Jul. 29 at 9:06 AM

$OVID Reply!

0 · Reply

Jtlo Jul. 28 at 9:14 PM

$ADIL dayummm $OVID was on track being the leader - adil leads in first place Can $INTS catch up in 3rd?

0 · Reply

Sil24 Jul. 28 at 4:44 PM

$OVID back to 0.28 again?

0 · Reply

Sil24 Jul. 28 at 4:44 PM

$OVID so that wad it

0 · Reply

Stockmasterdebater Jul. 28 at 4:44 PM

$OVID zero faith in this piece of sh*t now

0 · Reply

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference

Jun 25, 2025, 8:00 AM EDT - 5 weeks ago

Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties

May 13, 2025, 8:00 AM EDT - 2 months ago

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Mar 11, 2025, 8:00 AM EDT - 5 months ago

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 8:00 AM EST - 5 months ago

Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors

Feb 27, 2025, 8:00 AM EST - 5 months ago

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 5, 2025, 8:00 AM EST - 6 months ago

Ovid Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Sep 11, 2024, 8:00 AM EDT - 11 months ago

Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth

Aug 19, 2024, 11:00 AM EDT - 1 year ago

Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm

Aug 18, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm

Aug 17, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Eligible To Participate In Fraud Investigation With Schall Law Firm

Aug 16, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Invited To Join In Fraud Investigation With Schall Law Firm

Aug 15, 2024, 11:00 AM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Encouraged To Join Fraud Investigation With Schall Law Firm

Aug 14, 2024, 10:30 PM EDT - 1 year ago

Ovid Therapeutics Inc Shareholders Invited To Join Fraud Investigation With Schall Law Firm

Aug 14, 2024, 1:15 AM EDT - 1 year ago

Ovid Therapeutics Inc Investors Welcome To Participate In Fraud Investigation With Schall Law Firm

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

Aug 12, 2024, 11:55 PM EDT - 1 year ago

Ovid Therapeutics Inc Investors Invited To Join Fraud Investigation With Schall Law Firm

Aug 9, 2024, 9:15 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Can Participate In Fraud Investigation With The Schall Law Firm

Aug 8, 2024, 4:00 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Eligible To Join Fraud Investigation With The Schall Law Firm

Aug 7, 2024, 11:30 PM EDT - 1 year ago

Investors Of Ovid Therapeutics Inc Can Join Fraud Investigation With The Schall Law Firm

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Ovid Therapeutics Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm

Aug 2, 2024, 10:00 AM EDT - 1 year ago

OVID Investors Have Opportunity to Join Ovid Therapeutics Inc. Fraud Investigation with the Schall Law Firm

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at Upcoming August Investor Conferences

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Jul 1, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations

Jun 17, 2024, 8:58 AM EDT - 1 year ago

What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?

TAK

Jun 17, 2024, 6:55 AM EDT - 1 year ago

Ovid Therapeutics Reports on Takeda's Announcement of Phase 3 Topline Study Results for Soticlestat

May 14, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results

May 13, 2024, 7:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Apr 9, 2024, 10:48 AM EDT - 1 year ago

Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024

Apr 4, 2024, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 8, 2024, 8:00 AM EST - 1 year ago

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results

Feb 28, 2024, 8:00 AM EST - 1 year ago

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Feb 6, 2024, 8:00 AM EST - 1 year ago

Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 1, 2023, 7:30 AM EST - 1 year ago

Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)

Nov 3, 2023, 8:00 AM EDT - 1 year ago

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

Oct 18, 2023, 8:00 AM EDT - 1 year ago

Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid's Cash Runway into 2026

Oct 10, 2023, 8:00 AM EDT - 1 year ago

Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit

Sep 26, 2023, 7:30 AM EDT - 2 years ago

Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023

Sep 20, 2023, 7:30 AM EDT - 2 years ago

Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics to Participate in Upcoming September Investor Conferences

Aug 4, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Updates

Aug 1, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023

Jun 28, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer

Jun 26, 2023, 8:00 AM EDT - 2 years ago

Ovid Therapeutics Added to Russell 3000® Index

Jakezilla727 Jul. 31 at 1:20 PM

0 · Reply

Jtlo Jul. 30 at 11:01 PM

$OVID looking for next leg up and hopefully that comes with updates on the phase 1 - Looking for 2-3

0 · Reply

Jakezilla727 Jul. 30 at 2:26 PM

$OVID let's go🔥 I think it has potential to rise to 55 get in on the dip, it's just the star to the day.

0 · Reply

Trade_Weaver Jul. 29 at 11:46 PM

$OVID lets send this to the mood

0 · Reply

Jtlo Jul. 29 at 11:42 AM

$INTS reminds me when I got into $VOR when it was .22 cents $OVID next leg up? Looking to be over a dollar soon 🤞

0 · Reply

lucabrix Jul. 29 at 9:06 AM

$OVID Reply!

0 · Reply

Jtlo Jul. 28 at 9:14 PM

$ADIL dayummm $OVID was on track being the leader - adil leads in first place Can $INTS catch up in 3rd?

0 · Reply

Sil24 Jul. 28 at 4:44 PM

$OVID back to 0.28 again?

0 · Reply

Sil24 Jul. 28 at 4:44 PM

$OVID so that wad it

0 · Reply

Stockmasterdebater Jul. 28 at 4:44 PM

$OVID zero faith in this piece of sh*t now

0 · Reply

Love_To_Learn Jul. 28 at 4:41 PM

$OVID applying lil pressure for beloved

0 · Reply

lucabrix Jul. 28 at 3:04 PM

$OVID wonderful buy opportunity!

0 · Reply

lucabrix Jul. 27 at 7:35 PM

$OVID weekly 50MA looks like a strong resistance, for now

0 · Reply

Sil24 Jul. 27 at 9:01 AM

$OVID maybe they dont need it?

0 · Reply

jeremy0916 Jul. 26 at 12:57 AM

$OVID Soon we will be at $6 bucks! Reverse split woo!

1 · Reply

huan73 Jul. 25 at 5:51 PM

$OVID https://uk.finance.yahoo.com/news/ovid-therapeutics-sells-ganaxolone-royalty-162236095.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAAdwJMcs6bQ-dljOOWD_o2eWTP4QXWcVj1ijrMCS4ewWUWuYYk8spjzf9-2tJa41_aO21cMOUi2jHA-yEYKa3KlEMcw7sd7q56FVpWTk_yh0A_MVEteK2MqROXDgkpiDzBe-UnHUQJwaDsAdVGpcVph5CTrR4VxlxE9t8qpQvGUM

0 · Reply

Jtlo Jul. 25 at 5:41 PM

$OVID damn… always have to be manipulated.. No idea how this is going to trade now- bio always fucks me in the end

0 · Reply

lucabrix Jul. 24 at 7:33 PM

$OVID green close, powerful hammer, ride goes on!

0 · Reply

Tazdoc88 Jul. 24 at 5:24 PM

$IXHL $OVID

0 · Reply

lucabrix Jul. 24 at 3:14 PM

$OVID time to load!!

0 · Reply

Tazdoc88 Jul. 24 at 1:11 PM

$IXHL $OVID is next

0 · Reply

HansDampf1 Jul. 24 at 12:50 PM

$OVID received their Nasdaq noncompliant notice on 2/10/2025. The deadline is roundabout 08.10.2025 before delisting. Correct? https://www.nasdaq.com/market-activity/stocks/non-compliant-company-list?page=3&rows_per_page=100

3 · Reply

Market Cap	35.56M
Revenue (ttm)	570,000.00
Net Income (ttm)	-26.43M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,636.84%
Debt to Equity Ratio	0.00

Volume	535,900
Avg Vol	1,822,088
Day's Range	N/A - N/A
Shares Out	71.11M
Stochastic %K	8%
Beta	0.20
Analysts	Strong Sell
Price Target	$2.88